Precision Immunotherapy™
investors-relations
Investor Relations

Email Alerts

Email Address *
Mailing Lists *




 
Enter the code shown above.

Financial Reports

Click on the links below for electronic versions of Opexa's annual report and proxy statement:

Adobe Acrobat Reader is required to view these files. Download it here.

If you wish to receive, without charge, a printed copy of Opexas current annual report and 10-K, as filed with the Securities and Exchange Commission, you may do so by contacting:

Opexa Therapeutics, Inc.
2635 N. Technology Forest Blvd.
The Woodlands, TX 77381
Attention: Investor Relations

Telephone: 281.775.0600